RETN and type 2 diabetes mellitus: Although visfatin serum levels were comparable between patients with or without type 2 diabetes or obesity, the authors observed a significant correlation between visfatin levels and biomarkers of liver and kidney dysfunction and other adipokines such as resistin and leptin.